Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06683768 · ClinicalTrials.gov registry record
A Real-world Study of the Safety of Hypertension Medication Therapy in Japanese Patients With Naïve Hypertension
A clinical trial, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- 40,563
- Enrollment target
NCT06683768 is a clinical trial that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 40,563 participants.
The verdict
NCT06683768 has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- 40,563 participants
- Enrollment target
Study Summary
This was a non-interventional, secondary use of data, retrospective, cohort study. The data extracted in this study was used as secondary use of collected patient information in the database, Japan Medical Data Survey (JAMDAS), owned by M3 Inc. (Tokyo, Japan). JAMDAS is a database that aggregates medical information and is constructed mainly from electronic medical record information of medical institutions, allowing real-time extraction of information entered in medical records, such as prescription status including drug switching and continuation, laboratory values, clinical evaluation scores, and comorbidities etc.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,563 participants |
| Start Date | 2023-02-28 |
| Est. Completion | 2023-11-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06683768
The ClinicalTrials.gov registry entry for NCT06683768 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40,563 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06683768 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06683768 about?
NCT06683768 is a clinical study titled "A Real-world Study of the Safety of Hypertension Medication Therapy in Japanese Patients With Naïve Hypertension". This was a non-interventional, secondary use of data, retrospective, cohort study. The data extracted in this study was used as secondary use of collected patient information in the database, Japan Medical Data Survey (JAMDAS), owned by M3 Inc. (Tokyo, Japan). JAMDAS is a database that aggregates me...
What is the current status of trial NCT06683768?
This trial is currently completed. The enrollment target is 40,563 participants. The study started on 2023-02-28. Estimated completion is 2023-11-08.
Who is sponsoring clinical trial NCT06683768?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.